$9.880
+0.101 (+1.02%)收盘时
GLAS 资讯
GLAS 事件
Company Reports Q2 Adjusted EBITDA of $5.7M
Reports Q2 adjusted EBITDA $5.7M. The company said, "As a result of the Company's previously announced deconsolidation of Glass House Retail, LLC effective June 12, 2026, the historical operating results of GHR through June 11, 2026, together with the loss recognized upon deconsolidation of GHR on June 12, 2026, are presented as discontinued operations for all periods presented. Prior-period results of operations have been retrospectively recast to conform to the current-period presentation. Beginning June 12, 2026, the Company's share of GHR's post-deconsolidation income or loss is recognized under the equity method and included in continuing operations. Unless otherwise noted, the results of operations discussed in this earnings release, including the non-GAAP financial measures presented herein, reflect the Company's continuing operations and exclude amounts classified as discontinued operations."
GlassHouse Completes First International CBD Sale to Europe
GlassHouse announced the completion of its first international sale of smokeable CBD biomass to Europe. The product sold was part of the initial commercial harvest of Greenhouse 4 of the company's Camarillo Farm. "Our initial hemp sale to Europe is a historic step for the company as it reflects the first sale of any Glass House product outside our home state of California," said Kyle Kazan, co-founder, chairman and CEO of Glass House. Longer term, Greenhouse 4 production is being positioned for supply into the proposed federal Medicare reimbursable CBD program.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。


